In October 2026, numerous new titles of movies, shows and documentaries will arrive at Netflix throughout the month. Here is the complete l...

Scientists injected mitochondria taken from a woman’s leg into both of her eyes in an experimental attempt to boost energy production in da...

Countries worldwide are lifting cannabis restrictions, leading to a global market resurgence. North America is spearheading this movement w...

In January, Congress passed an appropriations bill, which became law, that specified funding for more than 200 projects and activities.

Former tennis champion Arantxa Sánchez Vicario, who has won US Open, French Open and Grand Slam titles four times, lost millions after trus...

Eyestem Research has secured approval from India's CDSCO to begin Phase 2 clinical trials for its Eyecyte-RPE cell therapy. This treatment ...

A recent study published in Cancer reveals that a single dose of psilocybin, combined with therapy, offers long-lasting relief from depress...

A stockbroker seeks therapy for market-induced anxiety, revealing his emotions always contradict market movements. Through playful “exposur...

Limitless potential for future global advancements in gene therapies is originating from India, said Dr David Gamm.

The study on plasma therapy by the ICMR is still ongoing, and the results will be shared on completion of the study. The ambiguity, experts...

It is important for everyone to detect drop in vision at the earliest stage.

Washington, Aug 13 (IANS) Blue light from digital devices including smartphones could accelerate blindness, researchers have found.

The U.S. Food and Drug Administration on Wednesday approved a radical new one-time treatment from the Swiss drugmaker, weeks earlier than e...

As Narayana Nethralaya is fronting it, the focus is on ocular (eye) diseases, though Ghosh’s own area of work is in muscular dystrophy.

End-stage heart failure patients treated with stem cells harvested from their own bone marrow experienced 37 per cent fewer cardiac events.

The joint venture will leverage Sun Pharma’s global capabilities and experience in developing and manufacturing complex dosage forms and sp...

The 50:50 deal will leverage Sun Pharma’s global capabilities and experience in developing complex dosage forms and specialty pharmaceutica...